Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David M Gershenson
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
501 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Bristol Royal Infirmary
Bristol, England, United Kingdom
- Addenbrookes Hospital-Medical School
Cambridge, England, United Kingdom
- Hammersmith Hospital
London, England, United Kingdom
- Saint Bartholomew'S Hospital
London, England, United Kingdom
- University College London Hospital
London, England, United Kingdom
- Christie Hospital
Manchester, England, United Kingdom
- Musgrove Park Hospital
Somerset, England, United Kingdom
- Saint James'S University Hospital
West Yorkshire, England, United Kingdom
- Belfast City Hospital
Belfast, Northern Ireland, United Kingdom
- Western General Hospital
Edinburgh, Scotland, United Kingdom
- Beatson Oncology Center
Glasgow, Scotland, United Kingdom
- the Royal Marsden Nhs Foundation Trust-Chelsea
London, United Kingdom
- Nottingham City Hospital
Nottingham, United Kingdom
- Tennessee Valley Gynecologic Oncology
Huntsville, Alabama, United States
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Oncology and Hematology Llc
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Associates in Radiation Medicine
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- Chi Saint Vincent Cancer Center Hot Springs
Hot Springs, Arkansas, United States
- Sutter Auburn Faith Hospital
Auburn, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn
Auburn, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Mills-Peninsula Medical Center
Burlingame, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park
Cameron Park, California, United States
- Eden Hospital Medical Center
Castro Valley, California, United States
- Community Cancer Institute
Clovis, California, United States
- University Oncology Associates
Clovis, California, United States
- Sutter Davis Hospital
Davis, California, United States
- Palo Alto Medical Foundation-Fremont
Fremont, California, United States
- Memorial Medical Center
Modesto, California, United States
- Palo Alto Medical Foundation-Camino Division
Mountain View, California, United States
- Palo Alto Medical Foundation-Gynecologic Oncology
Mountain View, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Apr 2014
- Primary completion
- 4 Apr 2019
- Completion
- 27 Oct 2025
- Last update posted
- 13 Nov 2025
- Registered enrollment
- 260
- Registry id
- NCT02101788
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.